Disease activity in patients with long-lasting rheumatoid arthritis is associated with changes in peripheral blood lymphocyte subpopulations

被引:0
作者
Smolenska, Zaneta [2 ]
Pawlowska, Justyna [1 ]
Daca, Agnieszka [1 ]
Soroczynska-Cybula, Monika [1 ]
Witkowski, Jacek M. [1 ]
Bryl, Ewa [1 ]
机构
[1] Gdanski Uniwersytet Med, Katedra & Zaklad Fizjopatol, PL-80210 Gdansk, Poland
[2] Gdanski Uniwersytet Med, Klin Chorob Wewnetrznych Geriatrii & Chorob Tkank, PL-80210 Gdansk, Poland
来源
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2012年 / 122卷 / 12期
关键词
activation marker; CD28; disease activity; peripheral blood lymphocytes; rheumatoid arthritis; CD8(+) T-CELLS; CD28; EXPRESSION; SYNOVIAL-FLUID; B-LYMPHOCYTE; EXPANSION; OSTEOARTHRITIS; METHOTREXATE; ACTIVATION; THERAPY; JOINTS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION Rheumatoid arthritis (RA) is a chronic autoimmune disease and it is known that lymphocytes play a major role in its pathogenesis. However, there have been no comprehensive studies on the changes in peripheral blood lymphocyte (PBL) subpopulations expressing different clusters of differentiation (CD) in patients with long-lasting RA. OBJECTIVES The aim of our study was to measure the main subpopulations of PBL, expression of costimulatory marker CD28, and activation status of CD4(+) T cells depending on clinical disease activity in long-lasting RA. PATIENTS AND METHODS The study comprised 60 patients with RA and 19 healthy volunteers. Disease activity, the proportion and number of the main PBL subpopulations (T, B, natural killer [NK], and NK T cells [NKT]), the expression of costimulatory marker CD28, and the activation status of CD4(+) T cells were evaluated on the same day. A multicolor flow cytometry with marked monoclonal antibodies was used for the assessment of lymphocyte subpopulations. RESULTS The percentage of CD3(+)CD4(+), NKT, CD4(+)CD28(-), CD8(+)CD28(-), CD4(+)CD69(+), CD4(+)CD25(+), and CD4(+)HLA-DR+ was significantly higher in RA compared with the control group. A higher proportion of CD4(+)CD28(-) was associated with more active disease, while an inverse correlation was observed for B cells. The proportion of CD4(+)CD28(-) was not associated with disease activity. The number of CD4+CD69+ cells in RA patients increased with increasing DAS28, while the number of CD4(+)HLA-DR+ T cells showed no such association. CONCLUSION Our results have shown for the first time an association between the phenotype patterns of PBL T, B, and NKT and RA activity in patients with long-lasting disease, which reinforces the hypothesis that PBL play an important role in modifying or maintaining the disease activity.
引用
收藏
页码:591 / 598
页数:8
相关论文
共 42 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Optimal treatment of rheumatoid arthritis: EULAR recommendations for clinical practice [J].
Bijlsma, Johannes W. J. .
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (09) :347-353
[3]   Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis [J].
Bryl, E ;
Vallejo, AN ;
Matteson, EL ;
Witkowski, JM ;
Weyand, CM ;
Goronzy, JJ .
ARTHRITIS AND RHEUMATISM, 2005, 52 (10) :2996-3003
[4]   Down-regulation of CD28 expression by TNF-α [J].
Bryl, E ;
Vallejo, AN ;
Weyand, CM ;
Goronzy, JJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3231-3238
[5]   Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4 [J].
Bryl, E ;
Gazda, M ;
Foerster, J ;
Witkowski, JM .
BLOOD, 2001, 98 (04) :1100-1107
[6]   Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells [J].
Bryl, Ewa ;
Daca, Agnieszka ;
Jozwik, Agnieszka ;
Witkowski, Jacek M. .
IMMUNOLOGY, 2009, 128 (01) :e287-e295
[7]   B cells in rheumatoid arthritis [J].
Bugatti, Serena ;
Codullo, Veronica ;
Caporali, Roberto ;
Montecucco, Carlomaurizio .
AUTOIMMUNITY REVIEWS, 2007, 7 (02) :137-142
[8]  
Chaiamnuay Sumapa, 2005, Pathophysiology, V12, P203, DOI 10.1016/j.pathophys.2005.07.007
[9]   Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis [J].
Davila, E ;
Kang, YM ;
Park, YW ;
Sawai, H ;
He, XW ;
Pryshchep, S ;
Goronzy, JJ ;
Weyand, CM .
JOURNAL OF IMMUNOLOGY, 2005, 174 (11) :7292-7301
[10]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581